Processa Pharmaceuticals, Inc. Operating Lease, Weighted Average Discount Rate, Percent
Processa Pharmaceuticals, Inc. (PCSA) had Operating Lease, Weighted Average Discount Rate, Percent of 8.00% as of 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2024-05-10
- 2024-03-31: Operating Lease, Weighted Average Discount Rate, Percent 8.00%.
- 2023-12-31: Operating Lease, Weighted Average Discount Rate, Percent 8.00%.
- 2023-09-30: Operating Lease, Weighted Average Discount Rate, Percent 8.00%.
- 2023-06-30: Operating Lease, Weighted Average Discount Rate, Percent 8.00%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2024-03-31 | 8.00% 10-Q · filed 2024-05-10 |
| 2023-12-31 | 8.00% 10-K · filed 2024-03-29 |
| 2023-09-30 | 8.00% 10-Q · filed 2023-11-13 |
| 2023-06-30 | 8.00% 10-Q · filed 2023-08-10 |
| 2023-03-31 | 8.00% 10-Q · filed 2023-05-15 |
| 2022-12-31 | 8.00% 10-K · filed 2023-03-30 |
| 2022-09-30 | 8.00% 10-Q · filed 2022-11-08 |
| 2022-06-30 | 8.00% 10-Q · filed 2022-08-11 |
| 2022-03-31 | 8.00% 10-Q · filed 2022-05-12 |
| 2021-12-31 | 8.00% 10-K · filed 2022-03-30 |
| 2021-09-30 | 8.00% 10-Q · filed 2021-11-12 |
| 2021-06-30 | 8.00% 10-Q · filed 2021-08-12 |
| 2021-03-31 | 8.00% 10-Q · filed 2021-05-13 |
| 2020-12-31 | 8.00% 10-K · filed 2021-03-25 |
| 2020-09-30 | 8.00% 10-Q · filed 2020-11-12 |
| 2020-06-30 | 8.00% 10-Q · filed 2020-08-05 |
| 2020-03-31 | 8.00% 10-Q · filed 2020-05-15 |
| 2019-12-31 | 8.00% 10-K · filed 2020-03-06 |
| 2019-09-30 | 8.00% 10-Q · filed 2019-11-14 |
| 2019-06-30 | 8.00% 10-Q · filed 2019-08-14 |
| 2019-03-31 | 8.00% 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |